Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM. Rossi JF, et al. Among authors: tollerfield sm. J Clin Oncol. 2004 Apr 1;22(7):1260-7. doi: 10.1200/JCO.2004.05.012. J Clin Oncol. 2004. PMID: 15051774 Clinical Trial.
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA. Foran JM, et al. Among authors: tollerfield sm. J Clin Oncol. 1999 Feb;17(2):546-53. doi: 10.1200/JCO.1999.17.2.546. J Clin Oncol. 1999. PMID: 10080598 Clinical Trial.
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
Jackson G, Taylor P, Smith GM, Marcus R, Smith A, Chu P, Littlewood TJ, Duncombe A, Hutchinson M, Mehta AB, Johnson SA, Carey P, MacKie MJ, Ganly PS, Turner GE, Deane M, Schey S, Brookes J, Tollerfield SM, Wilson MP. Jackson G, et al. Among authors: tollerfield sm. Br J Haematol. 2001 Jan;112(1):127-37. doi: 10.1046/j.1365-2141.2001.02551.x. Br J Haematol. 2001. PMID: 11167793 Free article. Clinical Trial.
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect.
Dasgupta RK, Rule S, Johnson P, Davies J, Burnett A, Poynton C, Wilson K, Smith GM, Jackson G, Richardson C, Wareham E, Stars AC, Tollerfield SM, Morgan GJ. Dasgupta RK, et al. Among authors: tollerfield sm. Bone Marrow Transplant. 2006 Mar;37(5):455-61. doi: 10.1038/sj.bmt.1705271. Bone Marrow Transplant. 2006. PMID: 16435017 Clinical Trial.
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
Swerdlow AJ, Cooke R, Albertsson-Wikland K, Borgström B, Butler G, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Kiess W, Hokken-Koelega AC, Kuehni CE, Landier F, Maes M, Mullis PE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tollerfield S, Zandwijken GR, Carel JC. Swerdlow AJ, et al. Horm Res Paediatr. 2015;84(3):172-83. doi: 10.1159/000435856. Epub 2015 Jul 23. Horm Res Paediatr. 2015. PMID: 26227295 Free PMC article.
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
Swerdlow AJ, Cooke R, Beckers D, Borgström B, Butler G, Carel JC, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Hokken-Koelega ACS, Khan AJ, Kiess W, Kuehni CE, Mullis PE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tidblad A, Tollerfield S, Van Eycken L, Zandwijken GRJ. Swerdlow AJ, et al. J Clin Endocrinol Metab. 2017 May 1;102(5):1661-1672. doi: 10.1210/jc.2016-2046. J Clin Endocrinol Metab. 2017. PMID: 28187225 Free PMC article.
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ, Cooke R, Beckers D, Butler G, Carel JC, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Hokken-Koelega ACS, Khan AJ, Kiess W, Kuehni CE, Flück CE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tidblad A, Tollerfield S, Zandwijken GRJ. Swerdlow AJ, et al. J Clin Endocrinol Metab. 2019 Mar 1;104(3):658-664. doi: 10.1210/jc.2018-01133. J Clin Endocrinol Metab. 2019. PMID: 30137467 Free PMC article.
12 results